Agennix AG Schedules Conference Call on May 6, 2010 to Discuss First Quarter 2010 Financial Results

Agennix AG Schedules Conference Call on May 6, 2010 to Discuss First Quarter 2010 Financial Results

ID: 20049

(Thomson Reuters ONE) -
Agennix AG / Agennix AG Schedules Conference Call on May 6, 2010 to Discuss First Quarter 2010 Financial Results processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.

Martinsried/Munich (Germany), Princeton, NJ and Houston, TX, April 30, 2010 -
Agennix AG (Frankfurt Stock Exchange: AGX) today announced that the Company will
hold a conference call to discuss financial results for the first quarter of
2010 and to provide a business update. The results will be published on
Thursday, May 6, 2010 in advance of the conference call.
The conference call, which will be conducted in English, will be held on
Thursday, May 6, 2010 at 9 AM ET/ 3 PM CET.
A live webcast will be available on the Agennix Web site at www.agennix.com. A
replay will be available via the Web site following the live event.
Dial-in numbers for the call are as follows:

Participants from Europe:0049 (0)69 667775756
0044 (0)20 3003 2666
Participants from the U.S.:1-646-843-4608
Please dial in 10 minutes before the beginning of the meeting.

About Agennix
Agennix AG is a publicly traded biopharmaceutical company that is developing
novel therapies in areas of major unmet medical need to improve the length and
quality of life of seriously ill patients. The Company's most advanced program
is talactoferrin, an oral targeted therapy that has demonstrated activity in
randomized, double-blind, placebo-controlled Phase 2 studies in non-small cell
lung cancer, as well as in severe sepsis. Talactoferrin is currently in Phase 3
clinical trials in non-small cell lung cancer. Other clinical development
programs include RGB-286638, a multi-targeted kinase inhibitor in Phase 1
testing; the oral platinum-based compound satraplatin; and a topical gel form of
talactoferrin for diabetic foot ulcers. Agennix's registered seat is in




Heidelberg, Germany. The Company has three sites of operation:
Martinsried/Munich, Germany; Princeton, New Jersey and Houston, Texas. For
additional information, please visit the Agennix Web site at www.agennix.com.
This press release contains forward-looking statements, which express the
current beliefs and expectations of the management of Agennix AG. Such
statements are based on current expectations and are subject to risks and
uncertainties, many of which are beyond our control, that could cause future
results, performance or achievements to differ significantly from the results,
performance or achievements expressed or implied by such forward-looking
statements. Actual results could differ materially depending on a number of
factors, and we caution investors not to place undue reliance on the
forward-looking statements contained in this press release. Forward-looking
statements speak only as of the date on which they are made and Agennix
undertakes no obligation to update these forward-looking statements, even if new
information becomes available in the future.


For further information, please contact:


Agennix
AG
Investor Relations & Corporate Communications
Phone: +49 (0)89 8565 2693
ir(at)agennix.com


In the U.S.: Laurie
Doyle
Director, Investor Relations & Corporate Communications
Phone: +1 609 524 5884

laurie.doyle(at)agennix.com



Additional media contacts for Europe:
MC Services
AG
Phone: +49 (0) 89 210 228 0

Raimund
Gabriel
raimund.gabriel(at)mc-services.eu


Hilda
Juhasz
hilda.juhasz(at)mc-services.eu



Additional investor contact for Europe:
Trout International
LLC
Lauren Williams, Vice President
Phone: +44 207 936 9325
lwilliams(at)troutgroup.com



[HUG#1410480]



--- End of Message ---

Agennix AG
Im Neuenheimer Feld 515 Heidelberg Germany

ISIN: DE000A1A6XX4;
Listed: Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;






Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  IFCO delivers strong growth in Q1 2010 Announcement of filing of its 2009 Annual Report Form 20-F
Bereitgestellt von Benutzer: hugin
Datum: 30.04.2010 - 11:01 Uhr
Sprache: Deutsch
News-ID 20049
Anzahl Zeichen: 0

contact information:
Town:

Heidelberg



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 240 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Agennix AG Schedules Conference Call on May 6, 2010 to Discuss First Quarter 2010 Financial Results"
steht unter der journalistisch-redaktionellen Verantwortung von

Agennix AG (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

DGAP-News: Agennix AG Announces Liquidation ...

DGAP-News: Agennix AG / Key word(s): AGM/EGM Agennix AG Announces Liquidation 23.05.2013 / 10:48 --------------------------------------------------------------------- Munich (Germany) and Princeton, NJ, May 23, 2013 - Agennix AG (Frankfurt Stock E ...

DGAP-News: Agennix AG Provides Strategic Update ...

DGAP-News: Agennix AG / Key word(s): AGM/EGM Agennix AG Provides Strategic Update 09.04.2013 / 22:59 --------------------------------------------------------------------- / Press Release For Immediate Release Agennix AG Provides Strategic Update ...

Alle Meldungen von Agennix AG



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z